Avantax Advisory Services’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388K | Buy |
7,061
+614
| +10% | +$33.8K | ﹤0.01% | 1736 |
|
|
2025
Q1 | $456K | Buy |
6,447
+497
| +8% | +$35.1K | ﹤0.01% | 1563 |
|
|
2024
Q4 | $391K | Buy |
5,950
+1,630
| +38% | +$107K | ﹤0.01% | 1610 |
|
|
2024
Q3 | $304K | Sell |
4,320
-88
| -2% | -$6.19K | ﹤0.01% | 1738 |
|
|
2024
Q2 | $363K | Buy |
4,408
+997
| +29% | +$82.1K | ﹤0.01% | 1572 |
|
|
2024
Q1 | $298K | Buy |
+3,411
| New | +$298K | ﹤0.01% | 1295 |
|